|
Advertisement
|
|
Home > BioTrends
BioTrends
Biopharma industry boosting cell culture sector in India
Biotechnology will boost market for CO2 incubators in India
Market for LIMS opening up in India
Biotech growth boosting HPLC business
BioTrends
Funds Are Not a Constraint
Biotech entrepreneurs are looking for funds. Similarly Venture Capitalists (VCs) are also looking at newer areas of investment opportunity to reap maximum returns. Biotechnology is one of many newer areas VCs are eyeing.
BioTrends
"For years, we made fun of the former Soviet Union for the long queues to pick up perennially short essential items. How is the United States in 2004 any different," wrote an angry American in the New York Times, referring to the night long vigils and mad scramble and rationing for flu vaccines as the nation approached another winter.
Make BioPartnering a Mission
There is no doubt that strategic alliances and partnerships have become the cornerstone of R&D strategy in the global pharmaceutical industry. The apostle of genomic revolution, Dr William Haseltine, chairman and CEO of Human Genome Sciences along with other leading speakers like Dr Kiran Mazumdar-Shaw of Biocon and Dr Rashmi H Barbhaiya of Ranbaxy shared their experiences and relevance of partnerships at the Frost & Sullivan organized "Bio Partnerships Seminar 2004" in Delhi and Bangalore on the 17 and 19 March respectively. They pointed out that the pharma industry’s two-decade old business model of bringing together complementary knowledge, capabilities and experience for solving major medical needs is still relevant. And more
The opportunity space is in "r"&D
During a Biospora gathering in Bangalore, Dr Bala S Manian shared his thoughts on the biotech entrepreneurial opportunities in the India-US corridor. BioSpectrum captures his formulas.
IPO Boom likely in 2004
After a lull for 12-18 months, there has been buoyancy in the biotech market—globally as well as locally. Strong fundamentals, global uptrend, and the booming Indian stock markets give the right platform for the launch of biotech Initial Public Offerings (IPOs). A report on the Indian and global biotech IPO pipeline.
|
|
|
|
|
